Paul H.A. Quax

16.0k citations

295 papers · 11.7k indexed · h-index 59

Molecular Biology top 1%
Cancer Research top 0.2%
Immunology top 0.5%
Surgery top 1%
Oncology top 2%

Co-authors: Margreet R. de Vries J. Wouter Jukema Victor W.M. van Hinsbergh Jan H. Verheijen Jos Grimbergen A. Yaël Nossent Gerard Pasterkamp Marten A. Engelse
Topics: Protease and Inhibitor Mechanisms (60 papers)Angiogenesis and VEGF in Cancer (60 papers)Atherosclerosis and Cardiovascular Diseases (54 papers)
Cited by: Cancer Research Immunology and Allergy Immunology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Circulation
Partner nations: Netherlands United States Germany

In The Last Decade

Paul H.A. Quax

292 papers receiving 11.5k citations

Peers

Countries citing papers authored by Paul H.A. Quax

Since Specialization

Citations

This map shows the geographic impact of Paul H.A. Quax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul H.A. Quax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul H.A. Quax more than expected).

Fields of papers citing papers by Paul H.A. Quax

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul H.A. Quax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul H.A. Quax. The network helps show where Paul H.A. Quax may publish in the future.

Co-authorship network of co-authors of Paul H.A. Quax

This figure shows the co-authorship network connecting the top 25 collaborators of Paul H.A. Quax. A scholar is included among the top collaborators of Paul H.A. Quax based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul H.A. Quax. Paul H.A. Quax is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	N-6-Methyladenosine in Vasoactive microRNAs during Hypoxia; A Novel Role for METTL4 2022 ·International Journal of Molecular Sciences ·(unknown),(unknown),Paul H.A. Quax,A. Yaël Nossent	28
2	Short Hairpin RNA Gene Silencing of Prolyl Hydroxylase-2 with a Minicircle Vector Improves Neovascularization of Hindlimb Ischemia 2013 ·Human Gene Therapy ·M.A. Lijkwan,(unknown),(unknown),Koen E.A. van der Bogt,Mei Huang,Nigel G. Kooreman,Margreet R. de Vries,Hendrika A. B. Peters,Robert C. Robbins,Jaap F. Hamming,Paul H.A. Quax,Joseph C. Wu	28
3	Annexin A5 prevents post-interventional accelerated atherosclerosis development in a dose-dependent fashion in mice 2012 ·Atherosclerosis ·M.M. Ewing,Jacco C. Karper,M. Lourdes Sampietro,Margreet R. de Vries,K. Pettersson,J. Wouter Jukema,Paul H.A. Quax	24
4	Abstract 15644: A Fully Human Monoclonal IgG Phosphorylcholine Antibody Prevents Accelerated Atherosclerosis in Mice 2011 ·Circulation ·Knut Pettersson,M.M. Ewing,Margreet R. de Vries,(unknown),(unknown),(unknown),Frédéric Charlotte,J. Wouter Jukema,Ewa Ninio,(unknown),Paul H.A. Quax	2
5	SNPs in MicroRNA Binding Sites in 3′-UTRs of RAAS Genes Influence Arterial Blood Pressure and Risk of Myocardial Infarction 2011 ·American Journal of Hypertension ·A. Yaël Nossent,(unknown),Carine J.M. Doggen,Paul H.A. Quax,Søren P. Sheikh,Frits R. Rosendaal	75
6	A limited role for regulatory T cells in post‐ischemic neovascularization 2011 ·Journal of Cellular and Molecular Medicine ·(unknown),Luciën E. P. M. van der Vlugt,M.A. Lijkwan,A.J.N.M. Bastiaansen,Tim Sparwasser,Hermelijn H. Smits,Jaap F. Hamming,Paul H.A. Quax	19
7	Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors 2011 ·Journal of Cellular and Molecular Medicine ·Rutger J. Wierda,Hedwich F. Kuipers,Marja C.J.A. van Eggermond,Anne Benard,(unknown),(unknown),Sacha B. Geutskens,J. Wouter Jukema,Víctor E. Márquez,Paul H.A. Quax,Peter J. van den Elsen	22
8	Abstract 14685: RP105, A Cell Surface TLR4 Signaling Regulator, Enhances Atherosclerotic Plaque Formation 2011 ·Circulation ·Jacco C. Karper,Saskia C.A. de Jager,M.M. Ewing,J. Wouter Jukema,Johan Kuiper,Paul H.A. Quax	1
9	Annexin A5: genotypic risk marker for clinical restenosis after percutaneous coronary intervention 2010 ·European Heart Journal ·M.M. Ewing,Jeffrey J. W. Verschuren,M. Lourdes Sampietro,Margreet R. de Vries,Peter de Knijff,Paul H.A. Quax,J. Wouter Jukema	1
10	In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor 2009 ·Journal of Vascular Surgery ·D. Eefting,Margreet R. de Vries,Jos Grimbergen,Jacco C. Karper,J. Hajo van Bockel,Paul H.A. Quax	15
11	Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice 2009 ·Journal of Vascular Surgery ·D. Eefting,Ilze Bot,Margreet R. de Vries,Abbey Schepers,J. Hajo van Bockel,Theo J.C. van Berkel,Erik A.L. Biessen,Paul H.A. Quax	34
12	Critical Role of Tissue Kallikrein in Vessel Formation and Maturation 2009 ·Arteriosclerosis Thrombosis and Vascular Biology ·Oliver A. Stone,Christine Richer,Costanza Emanueli,Vincent van Weel,Paul H.A. Quax,Rajesh Katare,N Kraenkel,Paola Campagnolo,Lucíola S. Barcelos,Mauro Siragusa,Graciela B. Sala‐Newby,Danila Baldessari,Marina Mione,(unknown),Andrew V. Benest,Ayman Al Haj Zen,Julien Gonzalez,David O. Bates,François Alhenc‐Gelas,Paolo Madeddu	48
13	Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease 2008 ·European Heart Journal ·Douwe Pons,F. R. de Vries,Peter J. van den Elsen,Bastiaan T. Heijmans,Paul H.A. Quax,J. Wouter Jukema	138
14	Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists 2006 ·Cardiovascular Research ·Yvonne D. Krom,Nuno Pires,J. Wouter Jukema,Margreet R. de Vries,Rune R. Frants,L.M. Havekes,(unknown),Paul H.A. Quax	18
15	Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice 2006 ·Journal of Vascular Surgery ·Abbey Schepers,Nuno Pires,D. Eefting,Margreet R. de Vries,J. Hajo van Bockel,Paul H.A. Quax	24
16	Drug-eluting stents studies in mice: Do we need atherosclerosis to study restenosis? 2006 ·Vascular Pharmacology ·Nuno Pires,J. Wouter Jukema,Mat J.A.P. Daemen,Paul H.A. Quax	8
17	The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE3-Leiden mice 2006 ·Atherosclerosis* ·D. Eefting,Abbey Schepers,Margreet R. de Vries,Nuno Pires,Jos Grimbergen,Tonny Lagerweij,Lex Nagelkerken,Pascalle S. Monraats,J. Wouter Jukema,J. Hajo van Bockel,Paul H.A. Quax	34
18	Urokinase-Receptor/Integrin Complexes Are Functionally Involved in Adhesion and Progression of Human Breast Cancer in Vivo 2001 ·American Journal Of Pathology ·Gabri van der Pluijm,Bianca Sijmons,H J Vloedgraven,Chris van der Bent,Jan W. Drijfhout,(unknown),Paul H.A. Quax,Marcel Karperien,Socrates E. Papapoulos,Clemens W.G.M. Löwik	79
19	The Plasminogen Activator System in Extracellular Matrix Degradation 1992 ·Research at the University of Copenhagen (University of Copenhagen) ·Paul H.A. Quax,(unknown),(unknown),(unknown),(unknown),Georgia Barlovatz‐Meimon,(unknown),(unknown)	10
20	Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation. 1991 ·PubMed ·Paul H.A. Quax,Nina Marie Pedersen,Maria Teresa Masucci,(unknown),Keld Danø,Jan H. Verheijen,Francesco Blasi	80

About Paul H.A. Quax

Paul H.A. Quax is a scholar working on Immunology and Allergy, Cancer Research and Immunology, having authored 295 papers that have together received 11.7k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (60 papers), Angiogenesis and VEGF in Cancer (60 papers) and Atherosclerosis and Cardiovascular Diseases (54 papers). The work is most often cited by research in Cancer Research (3.0k citations), Immunology and Allergy (1.0k citations) and Immunology (2.6k citations). Paul H.A. Quax has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Margreet R. de Vries, J. Wouter Jukema, Victor W.M. van Hinsbergh, Jan H. Verheijen, Jos Grimbergen, A. Yaël Nossent, Gerard Pasterkamp, Marten A. Engelse, J. Hajo van Bockel and Imo E. Hoefer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact